Bio Farma’s Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma’s Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

Two Large Medical Groups Shun Medicare Advantage Plans

Signaling what may be an emerging national trend, two influential medical groups with San Diego-based Scripps Health are cancelling their Medicare Advantage contracts for 2024

September 26, 2023

Canopy Growth Sells Stock at US$4.29

Canopy Growth Announces US$30 Million Private Placement SMITHS FALLS, ON, Jan. 9, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED)

January 9, 2024

MDMA Assisted Therapy Approval And Commercialization Projected Within Calendar 2024 Timeline

As the Psychedelic Science 2023 Conference in Denver wears on, interesting tidbits of data are emerging into the public sphere. As attendees of the conference—hosted

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.